Vitargent Biotechnology Company Profile: Valuation & Investors

The company's biotechnology and testing services develops transgenic medaka and zebrafish fish embryo for conducting toxic laboratory tests, enabling industries ... Login Requestafreetrial VitargentBiotechnology ThisisaprofilepreviewfromthePitchBookPlatform. Requestafreetrial Overview Timeline Valuation&Funding CapTable Comparisons Competitors Patents Team BoardMembers ServiceProviders Signals Investors LeadPartnersonDeals Acquisitions Subsidiaries Exits VitargentBiotechnologyOverview Updatethisprofile Founded 2010 Status Private Employees 5 LatestDealType SeriesB2 Investors 9 VitargentBiotechnologyGeneralInformation Description Providerofbiotechnologyandtestingservices.Thecompany'sbiotechnologyandtestingservicesdevelopstransgenicmedakaandzebrafishfishembryoforconductingtoxiclaboratorytests,enablingindustriessuchascosmetics,skincare,foodandbeverageconglomeratetosafeguardtheirproductsagainstharmfulchemicals. ContactInformation Website www.vitargent.com OwnershipStatus PrivatelyHeld(backing) FinancingStatus VentureCapital-Backed PrimaryIndustry Biotechnology OtherIndustries LaboratoryServices(Healthcare) PrimaryOffice Unit203,16West Number12ScienceParkWestAvenue HongKong,HongKong HongKong +85223930000    Wantdetaileddataon3M+companies? Whatyouseeherescratchesthesurface Requestafreetrial Wanttodigintothisprofile? We’llhelpyoufindwhatyouneed Learnmore VitargentBiotechnologyValuation&Funding DealType Date Amount RaisedtoDate Post-Val Status Stage 5.LaterStageVC(SeriesB2) 04-Jul-2018 Completed GeneratingRevenue 4.LaterStageVC(SeriesB1) 01-Mar-2018 00000 Completed GeneratingRevenue 3.LaterStageVC(SeriesB) 26-May-2016 Completed GeneratingRevenue 2.EarlyStageVC(SeriesA) 20-Jan-2015 Completed Startup 1.Accelerator/Incubator 15-Oct-2010 Completed Startup ToviewVitargentBiotechnology’scompletevaluationandfundinghistory,requestaccess » VitargentBiotechnologyComparisons Description PrimaryIndustry HQLocation Employees TotalRaised PostValuation LastFinancingDetails Providerofbiotechnologyandtestingservices.Thecompany'sbiotechnologyandtestingservicesdevelopstransgenicmed Biotechnology HongKong,HongKong 5 Asof 2015 00000000000 00000000 colaborisnisiutaliquipexeacommodoconsequat.Duisauteiruredolorinreprehenderitinvolupt 000000000000000000(0000000000) Luxembourg,Luxembourg 00000 Asof 0000 00000 000000000 00000 000000 itessecillumdoloreeufugiatnullapariatur.Excepteursintoccaecatcupidatatnonproident,sunt 0000000000000 Saclay,France 000 Asof 0000 000000000000 AddComparison PitchBook’scomparisonfeaturegivesyouaside-by-sidelookatkeymetricsforsimilarcompanies.Personalizewhichdatapointsyouwanttoseeandcreatevisualizationsinstantly. Requestafreetrial VitargentBiotechnologyCompetitors(6) CompanyName FinancingStatus Location Employees TotalRaised LastFinancingDate/Type LastFinancingAmount EurofinsScientific Corporation Luxembourg,Luxembourg 00000 00000 000000000 00000 0000000000000000 FormerlyPE-Backed Saclay,France 000 000000000000 00000000000000000 PrivateEquity-Backed Rensselaer,NY 000 000000000000 0000000 VentureCapital-Backed Riga,Latvia 0 00000 0000000000 00000 0000000 PrivateEquity-Backed AnnArbor,MI 00000 00000000 ToviewVitargentBiotechnology’scompletecompetitorshistory,requestaccess » VitargentBiotechnologyPatents 8 TotalDocuments ApplicationsandGrants 000 TotalPatents Families 1 Granted 2 Pending 000 Expiring innext12mo VitargentBiotechnologyRecentPatentActivity PublicationID PatentTitle Status FirstFilingDate Technology(CPC) Citations GB-201811234-D0 Determinationofsafetygradeorscoreofaproduct Ceased 09-Jul-2018 000000000 EP-3594887-A1 Computingsystemandmethodfordeterminingsafetyindexofproduct Withdrawn 09-Jul-2018 000000000 0 US-20200013133-A1 Computingsystemandmethodfordeterminingsafetyindexofproduct Pending 09-Jul-2018 000000000 EP-3255430-A1 Toxicantassaysforcosmeticproductsusingteleostembryos Granted 08-Jun-2016 00000000000 0 EP-3255430-B1 Toxicantassaysforcosmeticproductsusingteleostembryos Active 08-Jun-2016 G01N33/5014 ToviewVitargentBiotechnology’scompletepatenthistory,requestaccess » VitargentBiotechnologyExecutiveTeam(5) Updatethisprofile Name Title BoardSeat ContactInfo JimmyTao ChiefExecutiveOfficer XuepingChenPh.D Co-Founder,ChiefTechnologyOfficer&Director EricChen Co-Founder,ChiefCommercialOfficer&Director JeffreyCheung Co-Founder,ChiefFinancialOfficer&Director,CorporateService You’reviewing4of5executiveteammembers.Getthefulllist » VitargentBiotechnologyBoardMembers(1) Name Representing Role Since PeterLiu WIHarperGroup Chairman 0000000 ToviewVitargentBiotechnology’scompleteboardmembershistory,requestaccess » VitargentBiotechnologySignals GrowthRate 0.80% WeeklyGrowth WeeklyGrowth 0.80%,93rd%ile -35.5%. 530% SizeMultiple 219x Median SizeMultiple 219x,100th%ile 0.00x 0.95x. 413Kx KeyDataPoints TwitterFollowers 5.5k SimilarwebUniqueVisitors 15.0K MajesticReferringDomains 314 PitchBook’snon-financialmetricshelpyougaugeacompany’stractionandgrowthusingwebpresenceandsocialreach. Requestafreetrial VitargentBiotechnologyInvestors(9) InvestorName InvestorType Holding InvestorSince ParticipatingRounds ContactInfo BridgefieldCapitalManagement PE/Buyout Minority 0000000 0000000 HeungKongGroupLimited Corporation Minority 0000000 0000000 LeoheCapital VentureCapital Minority 0000000 0000000 PwCChina Accelerator/Incubator Minority 0000000 0000000 InnoangelFund VentureCapital Minority 0000000 0000000 You’reviewing5of9investors.Getthefulllist » Readytogetstarted? Requestafreetrial  